| pubmed-article:19070393 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19070393 | lifeskim:mentions | umls-concept:C0019163 | lld:lifeskim |
| pubmed-article:19070393 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19070393 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:19070393 | lifeskim:mentions | umls-concept:C0524909 | lld:lifeskim |
| pubmed-article:19070393 | lifeskim:mentions | umls-concept:C0035020 | lld:lifeskim |
| pubmed-article:19070393 | lifeskim:mentions | umls-concept:C0971023 | lld:lifeskim |
| pubmed-article:19070393 | lifeskim:mentions | umls-concept:C0549178 | lld:lifeskim |
| pubmed-article:19070393 | lifeskim:mentions | umls-concept:C0280274 | lld:lifeskim |
| pubmed-article:19070393 | lifeskim:mentions | umls-concept:C1444662 | lld:lifeskim |
| pubmed-article:19070393 | lifeskim:mentions | umls-concept:C1533148 | lld:lifeskim |
| pubmed-article:19070393 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:19070393 | pubmed:dateCreated | 2009-1-16 | lld:pubmed |
| pubmed-article:19070393 | pubmed:abstractText | To evaluate the off-treatment durability of response in HBeAg-negative chronic hepatitis B patients who achieved a protocol-defined 'Response' (HBV-DNA<0.7MEq/mL and ALT<1.25xULN) with entecavir at 48 weeks and the efficacy of entecavir in patients treated beyond one year. | lld:pubmed |
| pubmed-article:19070393 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19070393 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19070393 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19070393 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19070393 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19070393 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19070393 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19070393 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19070393 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19070393 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19070393 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19070393 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:19070393 | pubmed:issn | 0168-8278 | lld:pubmed |
| pubmed-article:19070393 | pubmed:author | pubmed-author:TamezRicardoR | lld:pubmed |
| pubmed-article:19070393 | pubmed:author | pubmed-author:MartinPaulP | lld:pubmed |
| pubmed-article:19070393 | pubmed:author | pubmed-author:CarosiGiampie... | lld:pubmed |
| pubmed-article:19070393 | pubmed:author | pubmed-author:LaiChing-Lung... | lld:pubmed |
| pubmed-article:19070393 | pubmed:author | pubmed-author:ShouvalDaniel... | lld:pubmed |
| pubmed-article:19070393 | pubmed:author | pubmed-author:ChangTing-Tsu... | lld:pubmed |
| pubmed-article:19070393 | pubmed:author | pubmed-author:CheinquerHugo... | lld:pubmed |
| pubmed-article:19070393 | pubmed:author | pubmed-author:KaymakogluSab... | lld:pubmed |
| pubmed-article:19070393 | pubmed:author | pubmed-author:HanStevenS | lld:pubmed |
| pubmed-article:19070393 | pubmed:author | pubmed-author:YangJoannaJ | lld:pubmed |
| pubmed-article:19070393 | pubmed:author | pubmed-author:Brett-SmithHe... | lld:pubmed |
| pubmed-article:19070393 | pubmed:author | pubmed-author:TenneyDanielD | lld:pubmed |
| pubmed-article:19070393 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:19070393 | pubmed:volume | 50 | lld:pubmed |
| pubmed-article:19070393 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19070393 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19070393 | pubmed:pagination | 289-95 | lld:pubmed |
| pubmed-article:19070393 | pubmed:meshHeading | pubmed-meshheading:19070393... | lld:pubmed |
| pubmed-article:19070393 | pubmed:meshHeading | pubmed-meshheading:19070393... | lld:pubmed |
| pubmed-article:19070393 | pubmed:meshHeading | pubmed-meshheading:19070393... | lld:pubmed |
| pubmed-article:19070393 | pubmed:meshHeading | pubmed-meshheading:19070393... | lld:pubmed |
| pubmed-article:19070393 | pubmed:meshHeading | pubmed-meshheading:19070393... | lld:pubmed |
| pubmed-article:19070393 | pubmed:meshHeading | pubmed-meshheading:19070393... | lld:pubmed |
| pubmed-article:19070393 | pubmed:meshHeading | pubmed-meshheading:19070393... | lld:pubmed |
| pubmed-article:19070393 | pubmed:meshHeading | pubmed-meshheading:19070393... | lld:pubmed |
| pubmed-article:19070393 | pubmed:meshHeading | pubmed-meshheading:19070393... | lld:pubmed |
| pubmed-article:19070393 | pubmed:meshHeading | pubmed-meshheading:19070393... | lld:pubmed |
| pubmed-article:19070393 | pubmed:meshHeading | pubmed-meshheading:19070393... | lld:pubmed |
| pubmed-article:19070393 | pubmed:meshHeading | pubmed-meshheading:19070393... | lld:pubmed |
| pubmed-article:19070393 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19070393 | pubmed:articleTitle | Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: the case for continuous antiviral therapy. | lld:pubmed |
| pubmed-article:19070393 | pubmed:affiliation | Liver Unit, Hadassah - Hebrew University Hospital, Ein-Kerem, Jerusalem 91120, Israel. shouval@cc.huji.ac.il | lld:pubmed |
| pubmed-article:19070393 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19070393 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:19070393 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:19070393 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19070393 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19070393 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19070393 | lld:pubmed |
